Logos Global Management LP 13D/13G Filings for Bright Minds Biosciences Inc. (DRUG)

Logos Global Management LP 13D and 13G filings for Bright Minds Biosciences Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-23
6:09 pm
Purchase
2024-10-1613GBright Minds Biosciences Inc.
DRUG
Logos Global Management LP100,000
2.200%
100,000increase
(New Position)
Filing